May 28, 2020

The Niche

Knoepfler lab stem cell blog

Month: December 2017

4 min read

Every year I look into my stem cell crystal ball and make predictions for our field including regenerative medicine. Well, I don’t really look into a crystal ball, but I try to use a combination of what I’m hearing through the grapevine, stuff I’m reading, some info that is not yet in the public domain, and common sense to make predictions. Today’s post has my 20 predictions for next year, 2018. You can see my 2017 predictions and my grading of how I did here. …Read More

2 min read

Congratulations to Professor Michele De Luca, the winner of The Niche’s Stem Cell Person of the Year Award for 2017! He won the Award from a strong panel of 10 finalists. The award includes a $2,000 USD prize. I chose him because of his exceptional track record in stem cell and regenerative medicine science combined with a long record of advocating for responsible translational science. Dr. De Luca also led an international team that recently published a groundbreaking paper on epidermal regeneration in a …Read More

3 min read

Australian stem cell biotech Mesoblast announced that it has received regenerative medicine advanced therapy (RMAT) designation from the U.S. FDA. This is very good news for the company and an encouraging development for the field. Interestingly, last month the FDA clarified that there is expanded RMAT designation that can include gene therapies too. At the Meeting on the Mesa in October, an FDA official reportedly presented data indicating that about 1/3 applications for RMATs were granted (see image below from Twitter). This recently announced RMAT …Read More

6 min read

This post is my review of Star Wars The Last Jedi. I’m a sci-fi fan and have enjoyed the various Star Wars movies over the years so I had been looking forward to seeing the new movie, Star Wars: The Last Jedi (TLJ). Here is my review of TLJ and be forewarned that there are lots of spoilers ahead so if you haven’t seen it, stop reading now. Overall rating: B-. Again, many spoilers ahead! I’m not going to rehash the whole plot, but …Read More

5 min read

A new stem cell clinic lawsuit has popped up and this one, like some others, relates to a patient alleging vision loss due to a non-FDA approved stem cell offering and involves U.S. Stem Cell, Inc. (formerly called Bioheart). American stem cell clinics market direct-to-consumer stem cell offerings for a whole medical dictionary’s worth of health conditions including vision loss. However, while stem cells have real promise for being the basis of future, safe and effective treatments for various forms of vision loss based …Read More

4 min read

Each year I make a list of predictions for the year to come for the stem cell and regenerative medicine field. Then about a year later I grade myself on how I did as that year winds down. Here’s how I did in 2016. For 2017, late in 2016 I made 20 stem cell predictions. Let’s now see how I did. I was wrong on 6 out of the 20 predictions and mostly right on the rest with some others in the middle that I colored …Read More